WallStreetZenWallStreetZen

NASDAQ: VBLT
Vascular Biogenics Ltd Earnings & Revenue

OverviewEarnings
DividendOwnership

VBLT past earnings growth

How has VBLT's earnings growth performed historically?
Company
-6.67%
Industry
4%
Market
30.64%
VBLT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
VBLT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
VBLT's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

VBLT past revenue growth

How has VBLT's revenue growth performed historically?
Company
-14.32%
Industry
58.31%
Market
17.32%
VBLT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VBLT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VBLT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VBLT earnings and revenue history

Current Revenue
$658.0k
Current Earnings
-$32.3M
Current Profit Margin
-4,909.4%
VBLT's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

VBLT Return on Equity

Current Company
-103.4%
Current Industry
-34.3%
Current Market
186.2%
VBLT's Return on Equity (-103.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VBLT announces earnings.

VBLT Return on Assets

Current Company
-77.5%
Current Industry
-0.2%
VBLT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VBLT Return on Capital Employed

Current Company
-140.52%
Current Industry
11.7%
VBLT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VBLT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VBLT$658.00k-$31.16M-$32.30M-45.64%+2.57%
TTNP$572.00k-$10.01M-$10.18M+24.40%N/A
PULM$4.82M-$17.12M-$21.85M+60.53%N/A
IMRN$770.95k-$2.08M-$2.08M-9.84%N/A
GLMD$0.00-$22.64M-$22.68M-100.00%N/A
View Top Biotech Stocks

VBLT earnings dates

Next earnings date
May 15, 2023

Vascular Biogenics Earnings & Revenue FAQ

What were VBLT's earnings last quarter?

On Invalid Date, Vascular Biogenics (NASDAQ: VBLT) reported Q4 2022 earnings per share (EPS) of $0.05, up 58.33% year over year. Total Vascular Biogenics earnings for the quarter were -$3.27 million. In the same quarter last year, Vascular Biogenics's earnings per share (EPS) was $0.12.

If you're new to stock investing, here's how to buy Vascular Biogenics stock.

What was VBLT's earnings growth in the past year?

As of Q1 2023, Vascular Biogenics's earnings has grown -6.67% year over year. This is 10.67 percentage points lower than the US Biotechnology industry earnings growth rate of 4%. Vascular Biogenics's earnings in the past year totalled -$32.30 million.

What is VBLT's earnings date?

Vascular Biogenics's earnings date is Invalid Date. Add VBLT to your watchlist to be reminded of VBLT's next earnings announcement.

What was VBLT's revenue last quarter?

On Invalid Date, Vascular Biogenics (NASDAQ: VBLT) reported Q4 2022 revenue of $0.00 up 100% year over year. In the same quarter last year, Vascular Biogenics's revenue was $196.00 thousand.

What was VBLT's revenue growth in the past year?

As of Q1 2023, Vascular Biogenics's revenue has grown -14.32% year over year. This is 72.64 percentage points lower than the US Biotechnology industry revenue growth rate of 58.31%. Vascular Biogenics's revenue in the past year totalled $658.00 thousand.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.